Related Experiment Video
Updated: Sep 15, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Management of Insomnia Complaints by Non-Sleep Specialist Physicians: A French DELPHI Consensus
Pierre-Alexis Geoffroy1,2,3, Jean-Louis Pépin4, Marjorie Guillet5
1Department of Psychiatry and Addictology, AP-HP, GHU Paris Nord, DMU Neurosciences, Bichat - Claude Bernard Hospital, Paris, France.
Abstract:
Insomnia is the most prevalent sleep disorder and a major public health concern, affecting chronically up to 19% of the adult population in France. Despite its significant impact on quality of life, mental health, and cardiometabolic disease, insomnia disorder remains underdiagnosed and inadequately managed. General Practitioners (GPs) play a pivotal role in addressing insomnia complaints but often face constraints, such as limited consultation time and a lack of specialised training. To provide practical recommendations for non-sleep specialist physicians, a French Delphi consensus was conducted based on recent expert guidelines. A multidisciplinary Steering Committee formulated 21 clinical statements regarding the evaluation, severity assessment, management, and referral to sleep specialists of patients presenting with insomnia disorder. These statements were submitted to a panel of 37 GPs across France via two rounds of anonymous rating using a 9-point Likert scale. While a consensus was reached for 95% of the statements, encompassing initial evaluation, sleep hygiene recommendations, behavioural interventions, and referral criteria, controversies emerged regarding the prescription of hypnotics, underscoring areas requiring further clarification and education. Our results highlight the importance of tailored approaches in primary care, emphasising pragmatic strategies rather than highly specialised protocols. This French Delphi consensus provides a structured yet flexible framework to support insomnia disorder management by non-sleep specialist physicians, bridging the gap between guidelines and real-world clinical practice.
More Related Videos
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

